Kosin Med J.  2021 Dec;36(2):79-99. 10.7180/kmj.2021.36.2.79.

Psychosomatic Approach to Fibromyalgia Syndrome: Concept, Diagnosis and Treatment

• Lee SS

• KMID: 2524670
• DOI: http://doi.org/10.7180/kmj.2021.36.2.79

Abstract

Fibromyalgia syndrome (FMS) has chronic widespread pain (CWP) as a core symptom and a variety of associated somatic and psychological symptoms such as fatigue, sleep problems, cognitive disturbances, multiple somatic pain, and depression. FMS is the subject of considerable controversy in the realm of nosology, diagnosis, pathophysiology, and treatment. Moreover, the fact that FMS and mental illness are closely associated with each other might intensify the confusion for the distinction between FMS and mental disorders. This narrative literature review aims to provide the concept, diagnosis, and treatment of FMS from the integrative biopsychosocial and psychosomatic perspective. This article first explains the concepts of FMS as a disease entity of biopsychosocial model, and then summarizes the changes of diagnostic criteria over past three decades, differential diagnosis and comorbidity issue focused on mental illnesses. In addition, an overview of treatment of FMS is presented mainly by arranging the recommendations from the international guidelines which have been developed by four official academic associations.

Keyword

Biopsychosocial model; Comorbidity; Fibromyalgia; Psychosomatic medicine

Reference

1. Häuser W, Ablin J, Fitzcharles MA, Littlejohn G, Luciano JV, Usui C, et al. . Fibromyalgia Nat Rev Dis Primers. 2015; 1:15022.

2. Fitzcharles MA, Ste-Marie PA, Goldenberg DL, Pereira JX, Abbey S, Choinière M, et al. 2012; Canadian Guidelines for the diagnosis and management of fibromyalgia syndrome: executive summary. Pain Res Manag. 2013; 18:119–26.

3. Macfarlane GJ, Kronisch C, Dean LE, Atzeni F, Häuser W, Fluss E, et al. EULAR revised recommendations for the management of fibromyalgia. Ann Rheum Dis. 2017; 76:318–28.

4. Ghavidel-Parsa B, Bidari A, Amir Maafi A, Ghalebaghi B. The Iceberg Nature of Fibromyalgia Burden: The Clinical and Economic Aspects. Korean J Pain. 2015; 28:169–76.

5. Queiroz LP. Worldwide epidemiology of fibromyalgia. Curr Pain Headache Rep. 2013; 17:356-013-0356-5.

6. Wolfe F, Walitt B, Perrot S, Rasker JJ, Häuser W. Fibromyalgia diagnosis and biased assessment: Sex, prevalence and bias. PLoS One. 2018; 13:e0203755.

7. Kim SH, Bae GR, Lim HS. Prevalence and Risk Factors of Fibromyalgia Syndrome and Chronic Widespread Pain in Two Communities in Korea - First Report in Korean. J Rheum Dis. 2006; 13:18–25.

8. Lee HJ, Choi E, Nahm FS, Choi SS, Kim YH, Moon JY, et al. Prevalence of fibromyalgia in fourteen Korean tertiary care university hospital pain clinics. J Pain Res. 2018; 11:2417–23.

9. Häuser W, Sarzi-Puttini P, Fitzcharles MA. Fibromyalgia syndrome: under-, over- and misdiagnosis. Clin Exp Rheumatol. 2019; 37:Suppl 116. 90–7.

10. Clauw DJ. Fibromyalgia: a clinical review. JAMA. 2014; 311:1547–55.

11. Wolfe F. Fibromyalgia wars. J Rheumatol. 2009; 36:671–8.

12. Tavel ME. Somatic symptom disorders without known physical causes: one disease with many names? Am J Med. 2015; 128:1054–8.

13. Smythe HA. Unhelpful criteria sets for “diagnosis” and “assessment of severity” of fibromyalgia. J Rheumatol. 2011; 38:975–8.

14. Ahmed S, Aggarwal A, Lawrence A. THU0481 Validation of the proposed 2016 revision to 2010 ACR preliminary fibromyalgia diagnostic criteria in a tertiary care setting. Ann Rheum Dis. 2017; 76:388.

15. Walitt B, Nahin RL, Katz RS, Bergman MJ, Wolfe F. The Prevalence and Characteristics of Fibromyalgia in the 2012 National Health Interview Survey. PLoS One. 2015; 10:e0138024.

16. Perrot S, Choy E, Petersel D, Ginovker A, Kramer E. Survey of physician experiences and perceptions about the diagnosis and treatment of fibromyalgia. BMC Health Serv Res. 2012; 12:356-6963-12-356.

17. Ablin J, Fitzcharles MA, Buskila D, Shir Y, Sommer C, Häuser W. Treatment of fibromyalgia syndrome: recommendations of recent evidence-based interdisciplinary guidelines with special emphasis on complementary and alternative therapies. Evid Based Complement Alternat Med. 2013; 2013:485272.

18. Häuser W, Henningsen P. Fibromyalgia syndrome: a somatoform disorder? Eur J Pain. 2014; 18:1052–9.

19. Fitzcharles MA, Perrot S, Hauser W. Comorbid fibromyalgia: A qualitative review of prevalence and importance. Eur J Pain. 2018; 22:1565–76.

20. Garcia-Fontanals A, Portell M, García-Blanco S, Poca-Dias V, García-Fructuoso F, López-Ruiz M, et al. Vulnerability to Psychopathology and Dimensions of Personality in Patients With Fibromyalgia. Clin J Pain. 2017; 33:991–7.

21. Thieme K, Turk DC, Flor H. Comorbid depression and anxiety in fibromyalgia syndrome: relationship to somatic and psychosocial variables. Psychosom Med. 2004; 66:837–44.

22. Yunus MB. Central sensitivity syndromes: a new paradigm and group nosology for fibromyalgia and overlapping conditions, and the related issue of disease versus illness. Semin Arthritis Rheum. 2008; 37:339–52.

23. Sancassiani F, Machado S, Ruggiero V, Cacace E, Carmassi C, Gesi C, et al. The management of fibromyalgia from a psychosomatic perspective: an overview. Int Rev Psychiatry. 2017; 29:473–88.

24. Häuser W, Fitzcharles MA. Facts and myths pertaining to fibromyalgia. Dialogues Clin Neurosci. 2018; 20:53–62.

25. Gatchel RJ, Peng YB, Peters ML, Fuchs PN, Turk DC. The biopsychosocial approach to chronic pain: scientific advances and future directions. Psychol Bull. 2007; 133:581–624.

26. Wolfe F, Häuser W. Fibromyalgia diagnosis and diagnostic criteria. Ann Med. 2011; 43:495–502.

27. Häuser W, Schmutzer G, Brähler E, Glaesmer H. A cluster within the continuum of biopsychosocial distress can be labeled “fibromyalgia syndrome”-evidence from a representative German population survey. J Rheumatol. 2009; 36:2806–12.

28. Turk DC, Adams LM. Using a biopsychosocial perspective in the treatment of fibromyalgia patients. Pain Manag. 2016; 6:357–69.

29. Yunus MB. Editorial review: an update on central sensitivity syndromes and the issues of nosology and psychobiology. Curr Rheumatol Rev. 2015; 11:70–85.

30. Lee Y, Lee SS, Kim H, Kim H. Fibromyalgia from the psychiatric perspective. Korean J Psychosom Med. 2020; 28:99–107.

31. Asmundson GJG, Katz J. Understanding pain and posttraumatic stress disorder comorbidity: do pathological responses to trauma alter the perception of pain? Pain. 2008; 138:247–9.

32. Schwaller F, Fitzgerald M. The consequences of pain in early life: injury-induced plasticity in developing pain pathways. Eur J Neurosci. 2014; 39:344–52.

33. Van Houdenhove B, Egle UT. Fibromyalgia: a stress disorder? Piecing the biopsychosocial puzzle together. Psychother Psychosom. 2004; 73:267–75.

34. Choy E, Perrot S, Leon T, Kaplan J, Petersel D, Ginovker A, et al. A patient survey of the impact of fibromyalgia and the journey to diagnosis. BMC Health Serv Res. 2010; 10:102-6963-10-102.

35. Wolfe F, Schmukler J, Jamal S, Castrejon I, Gibson KA, Srinivasan S, et al. Diagnosis of Fibromyalgia: Disagreement Between Fibromyalgia Criteria and Clinician-Based Fibromyalgia Diagnosis in a University Clinic. Arthritis Care Res (Hoboken). 2019; 71:343–51.

36. Crofford L. Chapter 52: Fibromyalgia. Firestein G, Budd R, Gabriel S, McInnes I, O’Dell J, editors. Kelley and Firestein’s Textbook of Rheumatology. Elsevier;2017. p. 768–83.

37. Ablin JN, Wolfe F. A Comparative Evaluation of the 2011 and 2016 Criteria for Fibromyalgia. J Rheumatol. 2017; 44:1271–76.

38. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990; 33:160–72.

39. Lee SS. Part 19 Fibromyalgia, Chapter 2: Laboratory findings, Diagnosis and Treatment. Textbook of Rheumatology. 2nd edition. PanMun Education;2018. p. 665–72.

40. Lee SS. Diagnosis and Treatment of Fibromyalgia Syndrome. Korean J Med. 2013; 84:650–8.

41. Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Häuser W, Katz RS, et al. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia. J Rheumatol. 2011; 38:1113–22.

42. Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Häuser W, Katz RL, et al. 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum. 2016; 46:319–29.

43. Toda K. Preliminary diagnostic criteria for fibromyalgia should be partially revised: comment on the article by Wolfe et al. Arthritis Care Res (Hoboken). 2011; 63:308–9. author reply 309–10.

44. Häuser W, Perrot S, Sommer C, Shir Y, Fitzcharles MA. Diagnostic confounders of chronic widespread pain: not always fibromyalgia. Pain Rep. 2017; 2:e598.

45. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Arlington(VA): American Psychiatric Association;2013. p. 314. p. 322. p. 368. p. 413.

46. Lichtenstein A, Tiosano S, Amital H. The complexities of fibromyalgia and its comorbidities. Curr Opin Rheumatol. 2018; 30:94–100.

47. Pae CU, Luyten P, Marks DM, Han C, Park SH, Patkar AA, et al. The relationship between fibromyalgia and major depressive disorder: a comprehensive review. Curr Med Res Opin. 2008; 24:2359–71.

48. Chang MH, Hsu JW, Huang KL, Su TP, Bai YM, Li CT, et al. Bidirectional Association Between Depression and Fibromyalgia Syndrome: A Nationwide Longitudinal Study. J Pain. 2015; 16:895–902.

49. Raphael KG, Janal MN, Nayak S, Schwartz JE, Gallagher RM. Psychiatric comorbidities in a community sample of women with fibromyalgia. Pain. 2006; 124:117–25.

50. Kleykamp BA, Ferguson MC, McNicol E, Bixho I, Arnold LM, Edwards RR, et al. The Prevalence of Psychiatric and Chronic Pain Comorbidities in Fibromyalgia: an ACT-TION systematic review. Semin Arthritis Rheum. 2021; 51:166–74.

51. Bortolato B, Berk M, Maes M, McIntyre RS, Carvalho AF. Fibromyalgia and Bipolar Disorder: Emerging Epidemiological Associations and Shared Pathophysiology. Curr Mol Med. 2016; 16:119–36.

52. Kudlow PA, Rosenblat JD, Weissman CR, Cha DS, Kakar R, McIntyre RS, et al. Prevalence of fibromyalgia and co-morbid bipolar disorder: A systematic review and meta-analysis. J Affect Disord. 2015; 188:134–42.

53. Carvalho AF, Dimellis D, Gonda X, Vieta E, Mclntyre RS, Fountoulakis KN. Rapid cycling in bipolar disorder: a systematic review. J Clin Psychiatry. 2014; 75:e578–86.

54. Häuser W, Kosseva M, Uceyler N, Klose P, Sommer C. Emotional, physical, and sexual abuse in fibromyalgia syndrome: a systematic review with meta-analysis. Arthritis Care Res (Hoboken). 2011; 63:808–20.

55. Paras ML, Murad MH, Chen LP, Goranson EN, Sattler AL, Colbenson KM, et al. Sexual abuse and lifetime diagnosis of somatic disorders: a systematic review and meta-analysis. JAMA. 2009; 302:550–61.

56. Häuser W, Galek A, Erbslöh-Möller B, Köllner V, Kühn-Becker H, Langhorst J, et al. Posttraumatic stress disorder in fibromyalgia syndrome: prevalence, temporal relationship between posttraumatic stress and fibromyalgia symptoms, and impact on clinical outcome. Pain. 2013; 154:1216–23.

57. Dimsdale JE, Creed F, Escobar J, Sharpe M, Wulsin L, Barsky A, et al. Somatic Symptom Disorder: An important change in DSM. J Psychosom Res. 2013; 75:223–8.

58. Häuser W, Hausteiner-Wiehle C, Henningsen P, Brähler E, Schmalbach B, Wolfe F. Prevalence and overlap of somatic symptom disorder, bodily distress syndrome and fibromyalgia syndrome in the German general population: A cross sectional study. J Psychosom Res. 2020; 133:110111.

59. Axelsson E, Hedman-Lagerlöf M, Hedman-Lagerlöf E, Ljótsson B, Andersson E. Symptom Preoccupation in Fibromyalgia: Prevalence and Correlates of Somatic Symptom Disorder in a Self-Recruited Sample. Psychosomatics. 2020; 61:268–76.

60. Häuser W, Bialas P, Welsch K, Wolfe F. Construct validity and clinical utility of current research criteria of DSM-5 somatic symptom disorder diagnosis in patients with fibromyalgia syndrome. J Psychosom Res. 2015; 78:546–52.

61. Wolfe F, Walitt BT, Katz RS, Häuser W. Symptoms, the nature of fibromyalgia, and diagnostic and statistical manual 5 (DSM-5) defined mental illness in patients with rheumatoid arthritis and fibromyalgia. PLoS One. 2014; 9:e88740.

62. Frances A. The new somatic symptom disorder in DSM-5 risks mislabeling many people as mentally ill. BMJ. 2013; 346:f1580.

63. Attademo L, Bernardini F. Prevalence of personality disorders in patients with fibromyalgia: a brief review. Prim Health Care Res Dev. 2018; 19:523–8.

64. Bucourt E, Martaillé V, Mulleman D, Goupille P, Joncker-Vannier I, Huttenberger B, et al. Comparison of the Big Five personality traits in fibromyalgia and other rheumatic diseases. Joint Bone Spine. 2017; 84:203–7.

65. Penfold S, St Denis E, Mazhar MN. The association between borderline personality disorder, fibromyalgia and chronic fatigue syndrome: systematic review. BJPsych Open. 2016; 2:275–9.

66. Seto A, Han X, Price LL, Harvey WF, Bannuru RR, Wang C. The role of personality in patients with fibromyalgia. Clin Rheumatol. 2019; 38:149–57.

67. Frølund Pedersen H, Frostholm L, Søndergaard Jensen J, Ørnbøl E, Schröder A. Neuroticism and maladaptive coping in patients with functional somatic syndromes. Br J Health Psychol. 2016; 21:917–36.

68. Ablin JN, Amital H, Ehrenfeld M, Aloush V, Elkayam O, Langevitz P, et al. Guidelines for the diagnosis and treatment of the fibromyalgia syndrome. Harefuah. 2013; 152:742–7. 751750

69. Eich W, Häuser W, Arnold B, Jäckel W, Offenbächer M, Petzke F, et al. Fibromyalgia syndrome. Definition, classification, clinical diagnosis and prognosis. Schmerz. 2012; 26:247–58.

70. Eich W, Häuser W, Arnold B, Bernardy K, Brückle W, Eidmann U, et al. Fibromyalgia syndrome. General principles and coordination of clinical care and patient education. Schmerz. 2012; 26:268–75.

71. Cho KI. Women, Stress and Heart Health: Mindfulness-Based Stress Reduction and Cardiovascular Disease. Kosin Med J. 2016; 31:103–12.

72. National Center for Complemetary and Integrative Health [Internet]. Maryland: U.S. Department of Health and Human Services;[cited 2021 Aug 24]. Available from: https://www.nccih.nih.gov/health/complementary-alternative-or-integrative-health-whats-in-a-name.